Validity of serum survivin and Serum Fibulin-3 (Pg/mL) in discriminating benign from malignant respiratory diseases
Receiver operating characteristic (ROC) curves for serum survivin (A) and fibulin-3 (B) in predicting lung cancer (P>0.05) and (C and D) in diagnosing malignant pleural mesothelioma (P>0.05).